Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Primary ovarian insufficiency secondary to chemotherapy with inotuzumab ozogamicin and other agents.
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.
Single-molecule analysis reveals widespread structural variation in multiple myeloma.
Is It Worth It? Consequences of Definitive Head and Neck Reirradiation.
A novel cytidine deaminase affects antibody diversity.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A novel cytidine deaminase affects antibody diversity.
A novel cytidine deaminase affects antibody diversity. Cell. 2000 Sep 01; 102(5):541-4.
View in:
PubMed
subject areas
Animals
Antibody Diversity
Cytidine Deaminase
Enzyme Activation
Genes, Immunoglobulin
Humans
Immunoglobulin Class Switching
Immunologic Deficiency Syndromes
Models, Genetic
Mutation
Recombination, Genetic
RNA Editing
authors with profiles
Ursula B. Storb